Shyam Srinivasan
Stock Analyst at Goldman Sachs
(0.25)
# 4,502
Out of 4,692 analysts
83
Total ratings
46.2%
Success rate
-11.5%
Average return
Main Sectors:
Stocks Rated by Shyam Srinivasan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NSE: DIVISLAB Divi's Laboratories Limited | Upgraded: Buy | ₹6,375 → ₹8,035 | ₹9,199 | -12.65% | 6 | May 29, 2026 | |
| NSE: DRREDDY Dr. Reddy's Laboratories Limited | Downgraded: Sell | ₹1,200 → ₹1,075 | ₹1,167 | -7.84% | 6 | Apr 23, 2026 | |
| NSE: APOLLOHOSP Apollo Hospitals Enterprise Limited | Maintained: Buy | ₹7,850 → ₹8,550 | ₹8,857 | -3.47% | 2 | Dec 7, 2025 | |
| NSE: FORTIS Fortis Healthcare Limited | Downgraded: Hold | ₹700.00 → ₹965.00 | ₹910.00 | +6.04% | 2 | Dec 7, 2025 | |
| NSE: KIMS Krishna Institute of Medical Sciences Limited | Initiated Coverage: Buy | ₹900.00 | ₹761.40 | +18.20% | 1 | Dec 7, 2025 | |
| NSE: MAXHEALTH Max Healthcare Institute Limited | Initiated Coverage: Buy | ₹1,325 | ₹1,008 | +31.51% | 1 | Dec 7, 2025 | |
| NSE: ICICIPRULI ICICI Prudential Life Insurance Company Limited | Maintained: Hold | ₹625.00 → ₹650.00 | ₹505.20 | +28.66% | 3 | Oct 15, 2025 | |
| NSE: LAURUSLABS Laurus Labs Limited | Maintained: Sell | ₹675.00 → ₹750.00 | ₹1,906 | -60.65% | 8 | Oct 14, 2025 | |
| NSE: NEULANDLAB Neuland Laboratories Limited | Maintained: Buy | ₹15,750 → ₹17,225 | ₹23,002 | -25.12% | 5 | Oct 14, 2025 | |
| NSE: BIOCON Biocon Limited | Maintained: Hold | ₹345.00 → ₹335.00 | ₹408.40 | n/a | 6 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹800.00 → ₹775.00 | ₹405.45 | n/a | 5 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹1,300 → ₹1,250 | ₹1,645 | n/a | 3 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | ₹1,375 → ₹1,350 | ₹1,418 | n/a | 5 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | ₹1,435 → ₹1,525 | ₹2,852 | n/a | 5 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹1,975 | ₹2,156 | n/a | 4 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹265.00 → ₹250.00 | ₹212.76 | n/a | 3 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹830.00 → ₹890.00 | ₹544.30 | n/a | 2 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹465.00 | ₹418.75 | n/a | 1 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹1,860 → ₹2,015 | ₹1,749 | n/a | 3 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | ₹1,650 → ₹1,680 | ₹1,976 | n/a | 2 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | ₹1,325 | ₹1,919 | n/a | 1 | Apr 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | ₹1,475 → ₹1,500 | ₹1,913 | n/a | 4 | Apr 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | ₹1,350 | ₹447.80 | n/a | 1 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | ₹1,675 | ₹583.00 | n/a | 1 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹1,975 | ₹1,554 | n/a | 1 | Jan 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.86 | n/a | 1 | Jul 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $12.18 | n/a | 1 | May 2, 2016 |
Divi's Laboratories Limited
May 29, 2026
Upgraded: Buy
Price Target: ₹6,375 → ₹8,035
Current: ₹9,199
Upside: -12.65%
Dr. Reddy's Laboratories Limited
Apr 23, 2026
Downgraded: Sell
Price Target: ₹1,200 → ₹1,075
Current: ₹1,167
Upside: -7.84%
Apollo Hospitals Enterprise Limited
Dec 7, 2025
Maintained: Buy
Price Target: ₹7,850 → ₹8,550
Current: ₹8,857
Upside: -3.47%
Fortis Healthcare Limited
Dec 7, 2025
Downgraded: Hold
Price Target: ₹700.00 → ₹965.00
Current: ₹910.00
Upside: +6.04%
Krishna Institute of Medical Sciences Limited
Dec 7, 2025
Initiated Coverage: Buy
Price Target: ₹900.00
Current: ₹761.40
Upside: +18.20%
Max Healthcare Institute Limited
Dec 7, 2025
Initiated Coverage: Buy
Price Target: ₹1,325
Current: ₹1,008
Upside: +31.51%
ICICI Prudential Life Insurance Company Limited
Oct 15, 2025
Maintained: Hold
Price Target: ₹625.00 → ₹650.00
Current: ₹505.20
Upside: +28.66%
Laurus Labs Limited
Oct 14, 2025
Maintained: Sell
Price Target: ₹675.00 → ₹750.00
Current: ₹1,906
Upside: -60.65%
Neuland Laboratories Limited
Oct 14, 2025
Maintained: Buy
Price Target: ₹15,750 → ₹17,225
Current: ₹23,002
Upside: -25.12%
Biocon Limited
Aug 8, 2025
Maintained: Hold
Price Target: ₹345.00 → ₹335.00
Current: ₹408.40
Upside: n/a
Jul 24, 2025
Maintained: Buy
Price Target: ₹800.00 → ₹775.00
Current: ₹405.45
Upside: n/a
Jul 15, 2025
Maintained: Buy
Price Target: ₹1,300 → ₹1,250
Current: ₹1,645
Upside: n/a
Jul 15, 2025
Maintained: Sell
Price Target: ₹1,375 → ₹1,350
Current: ₹1,418
Upside: n/a
Jul 15, 2025
Maintained: Sell
Price Target: ₹1,435 → ₹1,525
Current: ₹2,852
Upside: n/a
Jul 15, 2025
Maintained: Hold
Price Target: ₹1,975
Current: ₹2,156
Upside: n/a
Jul 15, 2025
Maintained: Buy
Price Target: ₹265.00 → ₹250.00
Current: ₹212.76
Upside: n/a
Jul 8, 2025
Maintained: Buy
Price Target: ₹830.00 → ₹890.00
Current: ₹544.30
Upside: n/a
Jul 8, 2025
Maintained: Hold
Price Target: ₹465.00
Current: ₹418.75
Upside: n/a
Jul 8, 2025
Maintained: Buy
Price Target: ₹1,860 → ₹2,015
Current: ₹1,749
Upside: n/a
May 2, 2025
Maintained: Sell
Price Target: ₹1,650 → ₹1,680
Current: ₹1,976
Upside: n/a
Apr 26, 2025
Maintained: Sell
Price Target: ₹1,325
Current: ₹1,919
Upside: n/a
Apr 18, 2025
Maintained: Sell
Price Target: ₹1,475 → ₹1,500
Current: ₹1,913
Upside: n/a
Apr 8, 2025
Initiated Coverage: Buy
Price Target: ₹1,350
Current: ₹447.80
Upside: n/a
Feb 6, 2025
Maintained: Sell
Price Target: ₹1,675
Current: ₹583.00
Upside: n/a
Jan 19, 2025
Maintained: Hold
Price Target: ₹1,975
Current: ₹1,554
Upside: n/a
Jul 26, 2021
Maintained: Hold
Price Target: n/a
Current: $0.86
Upside: n/a
May 2, 2016
Initiated Coverage: Hold
Price Target: n/a
Current: $12.18
Upside: n/a